Zhan Jiezhao, Liu Jianping, Yang Jing, Huang Lin, Lu Yudie, Lu Xuanyi, Zhu Jiaoyang, Yang Sugeun, Shen Zheyu
School of Biomedical Engineering, Southern Medical University, 1023 Shatai South Road, Baiyun, Guangzhou, Guangdong 510515, China.
Department of Biomedical Science, BK21 FOUR Program in Biomedical Science and Engineering, Inha University College of Medicine, Incheon 22212, South Korea.
ACS Appl Mater Interfaces. 2023 Oct 4;15(39):46213-46225. doi: 10.1021/acsami.3c09066. Epub 2023 Sep 23.
Recently, nanozymes with peroxidase (POD)-like activity have shown great promise for ferroptosis-based tumor therapy, which are capable of transforming hydrogen peroxide (HO) to highly toxic hydroxyl radicals (OH). However, the unsatisfactory therapeutic performance of nanozymes due to insufficient endogenous HO and acidity at tumor sites has always been a conundrum. Herein, an ultrasmall gold (Au) @ ferrous sulfide (FeS) cascade nanozyme (AuNP@FeS) with HS-releasing ability constructed with an Au nanoparticle (AuNP) and an FeS nanoparticle (FeSNP) is designed to increase the HO level and acidity in tumor cells the collaboration between cascade reactions of AuNP@FeS and the biological effects of released HS, achieving enhanced OH generation as well as effective ferroptosis for tumor therapy. The cascade reaction in tumor cells is activated by the glucose oxidase (GOD)-like activity of AuNP in AuNP@FeS to catalyze intratumoral glucose into HO and gluconic acid; meanwhile, the released HS from AuNP@FeS reduces HO consumption by inhibiting intracellular catalase (CAT) activity and promotes lactic acid accumulation. The two pathways synergistically boost HO and acidity in tumor cells, thus inducing a cascade to generate abundant OH by catalyzing HO through the POD-like activity of FeS in AuNP@FeS and ultimately causing amplified ferroptosis. and experiments demonstrated that AuNP@FeS presents a superior tumor therapeutic effect compared to that of AuNP or FeS alone. This strategy represents a simple but powerful method to amplify ferroptosis with HS-releasing cascade nanozymes and will pave a new way for the development of tumor therapy.
最近,具有过氧化物酶(POD)样活性的纳米酶在基于铁死亡的肿瘤治疗中显示出巨大潜力,它们能够将过氧化氢(H₂O₂)转化为剧毒的羟基自由基(·OH)。然而,由于肿瘤部位内源性H₂O₂不足和酸度不够,纳米酶的治疗性能不尽人意,这一直是个难题。在此,设计了一种由金纳米颗粒(AuNP)和硫化亚铁纳米颗粒(FeSNP)构建的具有HS释放能力的超小金(Au)@硫化亚铁(FeS)级联纳米酶(AuNP@FeS),以提高肿瘤细胞中的H₂O₂水平和酸度,通过AuNP@FeS的级联反应与释放的HS的生物学效应之间的协同作用,实现增强的·OH生成以及有效的铁死亡用于肿瘤治疗。肿瘤细胞中的级联反应由AuNP@FeS中AuNP的葡萄糖氧化酶(GOD)样活性激活,以催化肿瘤内的葡萄糖转化为H₂O₂和葡萄糖酸;同时,AuNP@FeS释放的HS通过抑制细胞内过氧化氢酶(CAT)活性减少H₂O₂消耗,并促进乳酸积累。这两条途径协同提高肿瘤细胞中的H₂O₂和酸度,从而通过AuNP@FeS中FeS的POD样活性催化H₂O₂诱导级联反应生成大量·OH,最终导致放大的铁死亡。体内和体外实验表明,与单独的AuNP或FeS相比,AuNP@FeS具有优异的肿瘤治疗效果。该策略代表了一种用释放HS的级联纳米酶放大铁死亡的简单而有效的方法,并将为肿瘤治疗的发展开辟一条新途径。